Guangdong Biolight Meditech Co., Ltd. (SHE:300246)

SHE:300246 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	617.26	466.39	498.72	437.03	336.55	430.86
Short-Term Investments	-	263.97	322.21	342.83	-	-
Trading Asset Securities	13	-	-	-	-	52.2
Cash & Short-Term Investments	630.26	730.35	820.93	779.86	336.55	483.06
Cash Growth	6.49%	-11.03%	5.27%	131.72%	-30.33%	159.83%
Accounts Receivable	261.2	262.44	261.25	297.24	232.03	191.8
Other Receivables	39.53	54.72	27.59	25.22	26.26	13.89
Receivables	300.73	317.16	288.84	322.46	258.29	205.69
Inventory	226.72	232.07	220.37	200.57	193.5	148.18
Other Current Assets	67.05	54.1	41.26	33	41.41	29.53
Total Current Assets	1,225	1,334	1,371	1,336	829.76	866.46
Property, Plant & Equipment	905.91	911.18	888.73	737.85	584.72	442.18
Long-Term Investments	13.56	13.84	8.53	8.69	9.83	5.5
Goodwill	25.15	25.15	40.67	127.13	127.13	136.59
Other Intangible Assets	100.01	101.63	98.08	94.51	90.51	89.38
Long-Term Accounts Receivable	3.39	4.12	5.59	-	-	-
Long-Term Deferred Tax Assets	27.5	29.19	18.13	25	10.48	6.03
Long-Term Deferred Charges	40.88	39.81	40.85	25.91	31.85	30.13
Other Long-Term Assets	41.4	40.21	62.43	83.97	35.24	30.9
Total Assets	2,383	2,499	2,534	2,439	1,720	1,607
Accounts Payable	185.7	206.49	246.8	221.26	178.44	133.13
Accrued Expenses	14.78	43.5	38.87	49.57	37.35	57.31
Short-Term Debt	128.64	188.14	220.41	132.64	130.66	105.5
Current Portion of Long-Term Debt	47.86	40.7	50.37	14.55	8.06	-
Current Portion of Leases	-	6.65	6.45	5.95	4.47	-
Current Income Taxes Payable	6.24	1.98	3.08	3.98	3.37	7.17
Current Unearned Revenue	45.44	43.75	69.39	76.01	48.08	47.65
Other Current Liabilities	109.1	144.61	135.34	99.43	86.77	43.89
Total Current Liabilities	537.76	675.82	770.7	603.39	497.2	394.65
Long-Term Debt	397.31	388.05	284.16	252.97	205.21	162.21
Long-Term Leases	22.96	22.19	23.61	21.46	8.12	-
Long-Term Unearned Revenue	104.55	106.94	50.3	45.38	9.32	10.4
Long-Term Deferred Tax Liabilities	11.02	14.72	14.87	13.48	7.25	7.07
Other Long-Term Liabilities	-	-	1.81	-	0.03	-
Total Liabilities	1,074	1,208	1,145	936.68	727.13	574.33
Common Stock	264.58	264.58	264.58	175.79	146.09	146.09
Additional Paid-In Capital	408.04	408.04	408.03	504.38	-	15.83
Retained Earnings	527.49	513.04	584.48	684.82	698.15	701.16
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	53.58	53.04	53.81	51.09	49.64	54.85
Total Common Equity	1,234	1,219	1,311	1,416	893.89	917.93
Minority Interest	75.31	72.43	78.05	86.17	98.49	114.9
Shareholders' Equity	1,309	1,291	1,389	1,502	992.38	1,033
Total Liabilities & Equity	2,383	2,499	2,534	2,439	1,720	1,607
Total Debt	596.77	645.72	584.99	427.57	356.52	267.71
Net Cash (Debt)	33.49	84.63	235.94	352.29	-19.97	215.35
Net Cash Growth	-	-64.13%	-33.03%	-	-	12617.43%
Net Cash Per Share	0.13	0.32	0.89	1.35	-0.09	0.98
Filing Date Shares Outstanding	261.6	261.6	264.58	263.68	262.22	219.13
Total Common Shares Outstanding	261.6	261.6	264.58	263.68	219.14	219.13
Working Capital	687.01	657.87	600.7	732.5	332.56	471.81
Book Value Per Share	4.72	4.66	4.95	5.37	4.08	4.19
Tangible Book Value	1,109	1,092	1,172	1,194	676.25	691.96
Tangible Book Value Per Share	4.24	4.17	4.43	4.53	3.09	3.16
Buildings	-	582.36	308.84	244.21	216.58	224.73
Machinery	-	448.39	418.44	398.3	361.28	283.82
Construction In Progress	-	127.92	365.74	263.45	155.7	71.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.